Skip to main content

Advertisement

Log in

Volumetric study of brain MRI in a cohort of patients with neurotransmitter disorders

  • Paediatric Neuroradiology
  • Published:
Neuroradiology Aims and scope Submit manuscript

Abstract

Purpose

Inborn errors of neurotransmitters are rare monogenic diseases. In general, conventional neuroimaging is not useful for diagnosis. Nevertheless, advanced neuroimaging techniques could provide novel diagnosis and prognosis biomarkers. We aim to describe cerebral volumetric findings in a group of Spanish patients with neurotransmitter disorders.

Methods

Fifteen 3D T1-weighted brain images from the International Working Group on Neurotransmitter related Disorders Spanish cohort were assessed (eight with monoamine and seven with amino acid disorders). Volumes of cortical and subcortical brain structures were obtained for each patient and then compared with those of two healthy individuals matched by sex and age.

Results

Regardless of the underlying disease, patients showed a smaller total cerebral tissue volume, which was apparently associated with clinical severity. A characteristic volumetric deficit pattern, including the right Heschl gyrus and the bilateral occipital gyrus, was identified. In severe cases, a distinctive pattern comprised the middle and posterior portions of the right cingulate, the left superior motor area and the cerebellum. In succinate semialdehyde dehydrogenase deficiency, volumetric affection seems to worsen over life.

Conclusion

Despite the heterogeneity and limited size of our cohort, we found novel and relevant data. Total volume deficit appears to be a marker of severity, regardless of the specific neurotransmitter disease and irrespective of the information obtained from conventional neuroimaging. Volumetric assessment of individual brain structures could provide a deeper knowledge about pathophysiology, disease severity and specific clinical traits.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

GABA:

Gamma-aminobutyric acid

CSF:

Cerebrospinal fluid

MRI:

Magnetic resonance imaging

iNTD:

International Working Group on Neurotransmitter related Disorders

AADCD:

Aromatic amino acid decarboxylase deficiency

ADGTPCHD:

Autosomal dominant GTP cyclohydrolase deficiency

ARGTPCHD:

Autosomal recessive GTP cyclohydrolase deficiency

MAOA-BD:

Monoamine oxidase A and B deficiency

NKH:

Non-ketotic hyperglycinemia

PTPSD:

6-Pyruvoyl-tetrahydropterin synthase deficiency

SSADHD:

Succinate-semialdehyde-dehydroxylase deficiency

THD:

Tyrosine hydroxylase deficiency

References

  1. Pearl PL, Wallis DD, Gibson KM (2004) Pediatric neurotransmitter diseases. Curr Neurol Neurosci Rep 4(2):147–152

    Article  Google Scholar 

  2. Pearl PL (2013) Monoamine neurotransmitter deficiencies. Handb Clin Neurol 113:1819–1825

    Article  Google Scholar 

  3. Ng J, Zhen J, Meyer E, Erreger K, Li Y, Kakaret N et al (2014) Dopamine transporter deficiency syndrome: phenotypic spectrum from infancy to adulthood. Brain 137(Pt 4):1107–1119

    Article  Google Scholar 

  4. Brennenstuhl H, Jung-Klawitter S, Assmann B, Opladen T (2019) Inherited disorders of neurotransmitters: classification and practical approaches for diagnosis and treatment. Neuropediatrics 50(1):2–14

    Article  CAS  Google Scholar 

  5. KuseyriHübschmann O, Horvath G, Cortès-Saladelafont E, Yıldız Y, Mastrangelo M, Pons R et al (2021) Insights into the expanding phenotypic spectrum of inherited disorders of biogenic amines. Nat Commun 20 12(1):5529

    Article  CAS  Google Scholar 

  6. Kuseyri Hübschmann O, Mohr A, Friedman J, Manti F, Horvath G, Cortès-Saladelafont E et al (2021) Brain MR patterns in inherited disorders of monoamine neurotransmitters: an analysis of 70 patients. J Inherit Metab Dis 44(4):1070–1082

    Article  CAS  Google Scholar 

  7. Ng J, Papandreou A, Heales SJ, Kurian MA (2015) Monoamine neurotransmitter disorders-clinical advances and future perspectives. Nat Rev Neurol 11(10):567–584

    Article  CAS  Google Scholar 

  8. Van der Crabben SN, Verhoeven-Duif NM, Brilstra EH, Van Maldergem L, Coskun T, Rubio-Gozalbo E et al (2013) An update on serine deficiency disorders. J Inherit Metab Dis 36(4):613–619

    Article  CAS  Google Scholar 

  9. Didiášová M, Banning A, Brennenstuhl H, Jung-Klawitter S, Cinquemani C, Opladen T et al (2020) Succinic semialdehyde dehydrogenase deficiency an update. Cells 19 9(2):477

    Article  CAS  Google Scholar 

  10. Nonketotic Hyperglycinemia.2019 GeneReviews® [Internet] Seattle

  11. Wei SH, Weng WC, Lee NC, Hwu WL, Lee WT (2011) Unusual spinal cord lesions in late-onset non-ketotic hyperglycinemia. J Child Neurol 26(7):900–903

    Article  Google Scholar 

  12. Zubarioglu T, Kiykim E, Cansever MS, Aktuglu Zeybek C, Yalcinkaya C (2016) Neonatal nonketotic hyperglycinemia: diffusion-weighted magnetic resonance imaging and diagnostic clues. Acta Neurol Belg 116(4):671–673

    Article  Google Scholar 

  13. Lee W, Weng W, Peng S, Tzen K (2009) Neuroimaging findings in children with paediatric neurotransmitter diseases. J Inherit Metab Dis 32(3):361–370

    Article  CAS  Google Scholar 

  14. Yamakawa Y, Nakazawa T, Ishida A, Saito N, Komatsu M, Matsubara T et al (2012) A boy with a severe phenotype of succinic semialdehyde dehydrogenase deficiency. Brain Dev 34(2):107–112

    Article  Google Scholar 

  15. Damseh N, Simonin A, Jalas C, Picoraro JA, Shaag A, Cho MT et al (2015) Mutations in SLC1A4, encoding the brain serine transporter, are associated with developmental delay, microcephaly and hypomyelination. J Med Genet 52(8):541–547

    Article  CAS  Google Scholar 

  16. de Koning TJ, Jaeken J, Pineda M, Van Maldergem L, Poll-The BT, van der Knaap MS (2000) Hypomyelination and reversible white matter attenuation in 3-phosphoglycerate dehydrogenase deficiency. Neuropediatrics 31(6):287–292

    Article  Google Scholar 

  17. Bjoraker KJ, Swanson MA, Coughlin CR, Christodoulou J, Tan ES, Fergeson M et al (2016) Neurodevelopmental outcome and treatment efficacy of benzoate and dextromethorphan in siblings with attenuated non-ketotic hyperglycinemia. J Pediatr 170:234–239

    Article  CAS  Google Scholar 

  18. Avants B, Epstein C, Grossman M, Gee J (2008) Symmetric diffeomorphic image registration with cross-correlation: evaluating automated labeling of elderly and neurodegenerative brain. Med Image Anal 12:26–41

    Article  CAS  Google Scholar 

  19. Ye J, Yang Y, Yu W, Zou H, Jiang J, Yang R et al (2013) Demographics, diagnosis and treatment of 256 patients with tetrahydrobiopterin deficiency in mainland China: results of a retrospective, multicentre study. J Inherit Metab Dis 36(5):893–901

    Article  Google Scholar 

  20. Mohammad SA, Abdelkhalek HS (2017) Nonketotic hyperglycinemia: spectrum of imaging findings with emphasis on diffusion weighted imaging. Neuroradiology 59:1155–1163

    Article  Google Scholar 

  21. Stence NV, Fenton LZ, Levek C, Tong S, Coughlin CR, Hennermann JB et al (2019) Brain imaging in classic nonketotic hyperglycinemia: quantitative analysis and relation to phenotype. J Inherit Metab Dis 42(3):438–450

    Article  CAS  Google Scholar 

  22. Lakhani R, Vogel KR, Till A, Liu J, Burnett SF, Gibson KM, Subramani S (2014) Defects in GABA metabolism affect selective autophagy pathways and are alleviated by mTOR inhibition. EMBO Mol Med 6(4):551–66. https://doi.org/10.1002/emmm.201303356

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  23. Wassenberg T, Molero-Luis M, Jeltsch K, Hoffmann GF, Assmann B, Blau N et al (2017) Consensus guideline for the diagnosis and treatment of aromatic l amino acid decarboxylase (AADC) deficiency. Orphanet J Rare Dis 18(12):1–12

    Google Scholar 

  24. Lee WT, Lin JH, Weng WC, Peng SF (2016) Microstructural changes of brain in patients with aromatic L-amino acid decarboxylase deficiency. Hum Brain Mapp 38(3):1532–1540

    Article  Google Scholar 

  25. Xing L, Huttner WB (2020) Neurotransmitters as modulators of neural progenitor cell proliferation during mammalian neocortex development. Front Cell Dev Biol 8:391

    Article  Google Scholar 

  26. Cameron HA, Hazel TG, Mckay RD (1998) Regulation of neurogenesis by growth factors and neurotransmitters. J Neurobiol 36:287–306

    Article  CAS  Google Scholar 

  27. Salazar P, Velasco-Velazquez MA, Velasco I (2008) GABA effects during neuronal differentiation of stem cells. Neurochem Res 33:1546–1557

    Article  CAS  Google Scholar 

  28. Van Horn MR, Sild M, Ruthazer ES (2013) D-serine as a gliotransmitter and its roles in brain development and disease. Front Cell Neurosci 23(7):39

    Google Scholar 

  29. Zhang Y, Bhavnani BR (2006) Glutamate-induced apoptosis in neuronal cells is mediated via caspase-dependent and independent mechanisms involving calpain and caspase-3 proteases as well as apoptosis inducing factor (AIF) and this process is inhibited by equine estrogens. BMC Neurosci 7:49

    Article  CAS  Google Scholar 

  30. Tabatabaie L, Klomp LW, Berger R, de Koning TJ (2010) l-Serine synthesis in the central nervous system: a review on serine deficiency disorders. Mol Genet Metab 99(3):256–262

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank the patients and their parents for their support and participation in this study.

Funding

This work was supported by the FIS P118/00111 “Instituto de Salud Carlos III (ISCIII)” and “Fondo Europeo de desarrollo regional (FEDER)”.

Author information

Authors and Affiliations

Authors

Contributions

Chiara Alfonsi: conceptualization; data curation; resources; formal analysis; investigation; methodology; writing—original draft.

Christian Stephan-Otto: conceptualization; formal analysis; investigation; methodology; resources; software; validation; writing—original draft.

Elisenda Cortès-Saladelafont: conceptualization; data curation; writing—original draft.

Inés Podzamczer-Valls: data curation.

Natalia Juliá Palacios, Nuria Gutiérrez Cruz, María Rosario Domingo Jiménez, Salvador Ibáñez Micó, Miguel Tomás Vila, Ramón Velázquez Fragua, Teresa Gómez, Oscar Alcoverro Fortuny, Inmaculada García Jiménez, Eduardo López Laso, Ana Roche Martínez: data curation; resources; writing—review and editing.

Kathrin Jeltsch, Oya Kuseyri Hübschmann, Thomas Opladen: writing—review and editing.

Muchart Jordi López: data curation; software; resources; writing—review and editing.

Àngels Garcia-Cazorla: conceptualization; funding acquisition; investigation; project administration; resources; supervision; validation; visualisation; writing—review and editing.

Corresponding author

Correspondence to Àngels Garcia-Cazorla.

Ethics declarations

Ethics approval

The study was approved by the local ethics committee (ID number: PIC-131–18). All the procedures were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2013.

Consent to participate

Oral and written informed consent was obtained from all subjects or their parents/legal guardians regarding publishing their data. Images from control subjects were obtained from a local anonymized MRI database, for which the patients or their parents/legal guardians gave informed consent.

Conflict of interest

Dr. Cortès-Saladelafont reports personal fees from Takeda, outside the submitted work. Dr. Kuseyri Hübschmann reports personal fees from PTC Therapeutics GT, outside the submitted work. Dr. López-Laso has received honoraria as an invited speaker and has also received consultation fees from PTC Therapeutics, outside the submitted work. Dr. Ibáñez-Micó reports grants and personal fees from PTC Therapeutics, during the conduct of the study. Dr. Alfonsi, Dr. Stephan-Otto, Dr. Juliá Palacios, Dr. Podzamczer-Valls, Dr. Nuria Gutiérrez, Dr. Kathrin Jeltsch, Dr. Velázquez Fragua, Dr. Alcoverro-Fortuny, Dr. Teresa Gómez, Dr. Roche Martínez and Dr. Muchart López have nothing to disclose.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 1.07 MB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alfonsi, C., Stephan-Otto, C., Cortès-Saladelafont, E. et al. Volumetric study of brain MRI in a cohort of patients with neurotransmitter disorders. Neuroradiology 64, 2179–2190 (2022). https://doi.org/10.1007/s00234-022-02989-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00234-022-02989-8

Keywords

Navigation